For instance, display of recombinant Affibody libraries has generated EGFR- and HER2-specific Affibody molecules, which have shown promising results for both tumour imaging and therapeutic applications [24], [25], [26], [27]. This evidence concerns the gene ERBB2 and neoplasm.